1 |
Moulding DA, Giles RV, Spiller DG, White MR, Tidd DM and Edwards SW (2000) Apoptosis is rapidly triggered by antisense depletion of MCL-1 in differentiating U937 cells. Blood 96, 1756-1763
|
2 |
Thallinger C, Wolschek MF, Wacheck V et al (2003) Mcl-1 antisense therapy chemosensitizes human melanoma in a SCID mouse xenotransplantation model. J Invest Dermatol 120, 1081-1096
DOI
ScienceOn
|
3 |
Nencioni A, Hua F, Dillon CP et al (2005) Evidence for a protective role of Mcl-1 in proteasome inhibitor-induced apoptosis. Blood 105, 3255-3262
DOI
ScienceOn
|
4 |
Han J, Goldstein LA and Gastman BR (2006) Interrelated roles for Mcl-1 and BIM in regulation of TRAIL-mediated mitochondrial apoptosis. J Biol Chem 281, 10153-10163
DOI
ScienceOn
|
5 |
Maurer U, Charvet C, Wagman AS, Dejardin E and Green DR (2006) Glycogen synthase kinase-3 regulates mitochondrial outer membrane permeabilization and apoptosis by destabilization of Mcl-1. Mol. Cell 21, 749-760
DOI
ScienceOn
|
6 |
Pozo-Guisado E, Merino JM, Mulero-Navarro S et al (2005) Resveratrol-induced apoptosis in MCF-7 human breast cancer cells involves a caspase-independent mechanism with downregulation of Bcl-2 and NF-kappaB. Int J Cancer 115, 74-84
DOI
ScienceOn
|
7 |
Tolomeo M, Grimaudo S, Di Cristina A et al (2005) Pterostilbene and 3'-hydroxypterostilbene are effective apoptosis-inducing agents in MDR and BCR-ABL-expressing leukemia cells. Int J Biochem Cell Biol 37, 1709-1726
DOI
ScienceOn
|
8 |
Augustine CK, Toshimitsu H, Jung SH et al (2010) Sorafenib, a multikinase inhibitor, enhances the response of melanoma to regional chemotherapy. Mol Cancer Ther 9, 2090-2101
DOI
|
9 |
Lee YJ, Im JH, Lee DM et al (2012) Synergistic inhibition of mesothelioma cell growth by the combination of clofarabine and resveratrol involves Nrf2 downregulation. BMB Rep 45, 647-652
DOI
ScienceOn
|
10 |
Simonin K, Brotin E, Dufort S et al (2009) Mcl-1 is an important determinant of the apoptotic response to the BH3-mimetic molecule HA14-1 in cisplatin-resistant ovarian carcinoma cells. Mol Cancer Ther 8, 3162-3170
DOI
ScienceOn
|
11 |
Kitada S, Anderson J and Akar S (1998) Expression of apoptosis-regulating proteins in chronic lymphocytic leukemia: correlations with in vitro and in vivo chemoresponses. Blood 91, 3379-3389
|
12 |
Lee YJ, Lee YJ, Im JH et al (2013) Synergistic anti-cancer effects of resveratrol and chemotherapeutic agent clofarabine against human malignant mesothelioma MSTO-211H cells. Food Chem Toxicol 52, 61-68
DOI
ScienceOn
|
13 |
Shroff EH, Snyder C, Chandel NS (2007) Bcl-2 family members regulate anoxia-induced cell death. Antioxid Redox Signal 9, 1405-1409
DOI
ScienceOn
|
14 |
O'Kane SL, Pound RJ, Campbell A, Chaudhuri N, Lind MJ and Cawkwell L (2006) Expression of bcl-2 family members in malignant pleural mesothelioma. Acta Oncol 45, 449-453
DOI
ScienceOn
|
15 |
Craig RW (2002) MCL1 provides a window on the role of the BCL2 family in cell proliferation, differentiation and tumorigenesis. Leukemia 16, 444-454
DOI
ScienceOn
|
16 |
Nijhawan D, Fang M, Traer E et al (2003) Elimination of Mcl-1 is required for the initiation of apoptosis following ultraviolet irradiation. Genes Dev 17, 1475-1486
DOI
ScienceOn
|
17 |
Montanaro F, Rosato R, Gangemi M et al (2009) Survival of pleural malignant mesothelioma in Italy: a population-based study. Int J Cancer 124, 201-207
DOI
ScienceOn
|
18 |
Barbone D, Cheung P, Battula S et al (2012) Vorinostat eliminates multicellular resistance of mesothelioma 3D spheroids via restoration of Noxa expression. PLoS One 7, e52753
DOI
|
19 |
Grimm D, Wehland M, Pietsch J, Infanger M and Bauer J (2011) Drugs interfering with apoptosis in breast cancer. Curr Pharm Des 17, 272-283
DOI
ScienceOn
|
20 |
Soini Y, Kinnula V, Kaarteenaho-Wiik R, Kurttila E, Linnainmaa K and Pääkkö P (1999) Apoptosis and expression of apoptosis regulating proteins bcl-2, mcl-1, bcl-X, and bax in malignant mesothelioma. Clin Cancer Res 5, 3508-3515
|
21 |
Shimazu T, Degenhardt K, Nur-E-Kamal A et al (2007) NBK/BIK antagonizes MCL-1 and BCL-XL and activates BAK-mediated apoptosis in response to protein synthesis inhibition. Genes Dev 21, 929-941
DOI
ScienceOn
|
22 |
Kaufmann SH, Karp JE, Svingen PA et al (1998) Elevated expression of the apoptotic regulator Mcl-1 at the time of leukemic relapse. Blood 91, 991-1000
|